According to a new report, the global cancer diagnostics market is anticipated to grow at 8.9% CAGR during the forecast period 2016-2026. The market was valued at over US$ 32 Bn in 2016, and it expected to surpass US$ 76 Bn in revenues by 2026.
Biopsy/Tissue Diagnostics Largest Segment by Test Type
By test type, the global cancer diagnostics market has been ... Read more
Biopsy is expected to remain the most lucrative cancer diagnostics test due to technological advancements such as fine needle aspiration
The biopsy test type segment dominated the global cancer diagnostics market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Biopsy is the largest segment, which was valued at more than US$ 11 Bn in 2016 and is expected ... Read more
Biopsy is expected to remain the most lucrative cancer diagnostics test due to technological advancements such as fine needle aspiration
The biopsy test type segment dominated the global cancer diagnostics market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Biopsy is the largest segment, which was valued at more than US$ 11 Bn in 2016 and is expected to expand at a CAGR of 7.4% over the forecast period. The liquid ... Read more
According to a new report, the global cancer diagnostics market is anticipated to grow at 8.9% CAGR during the forecast period 2016-2026. The market was valued at over US$ 32 Bn in 2016, and it expected to surpass US$ 76 Bn in revenues by 2026.
Biopsy/Tissue Diagnostics Largest Segment by Test Type
According to a new report, the global cancer diagnostics market is anticipated to grow at 8.9% CAGR during the forecast period 2016-2026. The market was valued at over US$ 32 Bn in 2016, and it expected to surpass US$ 76 Bn in revenues by 2026.
Biopsy/Tissue Diagnostics Largest Segment by Test Type
By test type, the global cancer diagnostics market has been segmented into tumour biomarker tests, imaging, biopsy, liquid biopsy, immunohistochemistry, and in situ hybridisation. ... Read more
Market Research Future published a research report on “Cancer Diagnostics Market – Forecast Up To 2023”. Report include market Analysis, Scope, Size, Share, Growth, Recent Trends and forecast in detail information. The market is projected to demonstrate a sound growth by 2023, Market will grow at a CAGR of 11.8% during forecasted period.
Cancer Diagnostics Market Highlights
There are several methods of diagnosing cancer today such as biopsy ... Read more
Market Research Future published a research report on “Cancer Diagnostics Market – Forecast Up To 2023”. Report include market Analysis, Scope, Size, Share, Growth, Recent Trends and forecast in detail information. The market is projected to demonstrate a sound growth by 2023, Market will grow at a CAGR of 11.8% during forecasted period.
Cancer Diagnostics Market Highlights
There are several methods of diagnosing cancer today such as biopsy ... Read more
With the tremendous rise in the prevalence of cancer across the world, the global market for cancer diagnostics is witnessing a remarkable surge in its size. The technological advancements in devices used in the diagnosis of cancer are also supporting the growth of this market, significantly. One of the main causes of deaths, globally, is cancer. Therefore, medical and healthcare professionals are concentrating on the ... Read more
Owing to the increase in the number of incidences of cancer and rise in the expenditure of healthcare sector, the global market for cancer diagnostics is expected to make a remarkable growth in the future years. Moreover, the technological advancement along with government initiatives and fund contribution that work in favor of the market are also factors estimated to fuel the growth of the market.
The detailed report that has been recently published by Market Research Future (MRFR) projects that the global cancer diagnostics market is marked to exhibit noteworthy expansion at a CAGR of 11.85% during the forecast period of 2017-2023. Rise in prevalence of individuals suffering from cancer and high demand for advanced diagnostic procedures in order to receive precise and effective treatment are majorly propelling the ... Read more
The rising burden of cancer globally has necessitated the adoption of developed cancer diagnostic solutions in the healthcare sector. It has a positive impact on the growth and expansion of the cancer diagnostics market at CAGR 11.8 %
Market Leading Players
C.R. Bard, Inc. (the U.S.), Philips Healthcare (the U.K.), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories, Inc. (the U.S.), QIAGEN N.V. (Netherlands), GE Healthcare ( ... Read more
The rising burden of cancer globally has necessitated the adoption of developed cancer diagnostic solutions in the healthcare sector. It has a positive impact on the growth and expansion of the cancer diagnostics market at CAGR 11.8 %
Market Leading Players
C.R. Bard, Inc. (the U.S.), Philips Healthcare (the U.K.), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories, Inc. (the U.S.), QIAGEN N.V. (Netherlands), GE Healthcare ( ... Read more
Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, rapidly rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the market growth.
The rising burden of cancer globally has necessitated the adoption of developed cancer diagnostic solutions in the healthcare sector. It has a positive impact on the growth and expansion of the cancer diagnostics market at CAGR 11.8 %
Market Leading Players
C.R. Bard, Inc. (the U.S.), Philips Healthcare (the U.K.), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories, Inc. (the U.S.), QIAGEN N.V. (Netherlands), GE Healthcare ( ... Read more
global cancer diagnostics market Research Report: Information by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer and others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) — Forecast till 2025
global cancer diagnostics market by technology Research Report: Information by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer and others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) — Forecast till 2025
The global Cancer Diagnostics market is estimated to be valued at US$ 59.1 billion in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The Cancer Diagnostics market includes various diagnostic tools and techniques used for the early detection, diagnosis, and management of cancer. These diagnostics play a crucial role in determining ... Read more
Cancer diagnostics involve various procedures and tests to detect cancer in the body and determine the stage and type. Diagnostics help identify cancer and locate it, which is crucial for determining the appropriate course of treatment. Common diagnostic tests for cancer include imaging tests such as X-rays, CT scans, MRIs, and PET scans. Other diagnostic tests include biopsy, endoscopy, lumbar puncture, and blood tests. Cancer diagnostics provide clinicians with critical information to ... Read more
